Medicare Enrolled
Dr. Charles Croft, MD, FACP, FACC
Cardiovascular Disease · Melbourne, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Croft from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Croft? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Croft
Dr. Charles Croft is a cardiovascular disease in Melbourne, FL, with 20 years in practice. Based on federal Medicare data, Dr. Croft performed 11,583 Medicare services across 6,086 unique beneficiaries.
Between the years covered by Open Payments, Dr. Croft received a total of $15,432 from 43 pharmaceutical and/or device companies across 333 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Croft is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 6% volume in FL$ $15,432 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,583
Medicare services
Top 6% in FL for cardiovascular disease
6,086
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~579 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 2,448 | $0 | $2 |
| Electrocardiogram (EKG), 12-lead | 1,410 | $10 | $42 |
| Office visit, established patient (30-39 min) | 1,230 | $91 | $265 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 445 | $25 | $90 |
| EKG interpretation and report | 427 | $7 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 341 | $11 | $32 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 339 | $18 | $64 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 330 | $88 | $295 |
| Hospital follow-up visit, moderate complexity | 325 | $63 | $183 |
| Remote pacemaker/defibrillator monitoring, 90 days | 319 | $13 | $56 |
| Initial hospital admission, high complexity | 290 | $139 | $510 |
| Echocardiogram, transthoracic | 258 | $92 | $346 |
| Office visit, established patient (20-29 min) | 227 | $61 | $179 |
| Ultrasonic guidance for blood vessel access | 201 | $12 | $37 |
| Remote pacemaker monitoring, 90 days | 196 | $17 | $76 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 166 | $47 | $176 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 165 | $322 | $1,199 |
| Blood draw (venipuncture) | 157 | $8 | $8 |
| New patient office visit, complex (60-74 min) | 157 | $158 | $513 |
| Injection, dipyridamole, per 10 mg | 134 | $3 | $8 |
| Cardiac catheterization | 133 | $195 | $792 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 124 | $21 | $95 |
| Programming of dual lead pacemaker system | 120 | $54 | $144 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 111 | $20 | $66 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 111 | $626 | $1,771 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 110 | $19 | $64 |
| Coronary stent placement | 108 | $459 | $1,588 |
| Evaluation of implantable heart and blood vessel monitoring system | 94 | $37 | $90 |
| Review by radiologist of arm or leg artery image | 93 | $69 | $221 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 93 | $255 | $1,007 |
| Natriuretic peptide (heart and blood vessel protein) level | 87 | $38 | $99 |
| Initial hospital admission, moderate complexity | 76 | $105 | $345 |
| Injection for imaging of aorta above heart valve with review by radiologist | 75 | $33 | $141 |
| Repair of left upper heart chamber with implant with review by radiologist | 60 | $437 | $2,690 |
| Imaging guidance for procedure, 60 minutes or less | 59 | $13 | $23 |
| Review by radiologist of chest aorta serial images | 50 | $44 | $141 |
| Infusion of drug with evaluation of coronary artery spasm response | 50 | $44 | $143 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 50 | $68 | $257 |
| Programming of single lead implantable defibrillator system | 46 | $55 | $151 |
| Ultrasound of heart, follow-up | 43 | $19 | $66 |
| Injection for x-ray imaging procedure into vein of arm or leg | 31 | $20 | $127 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 29 | $40 | $88 |
| Programming of dual lead implantable defibrillator system | 29 | $76 | $194 |
| Ultrasound of both sides of head and neck blood flow | 28 | $146 | $503 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 20 | $432 | $1,385 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 19 | $238 | $899 |
| Removal and replacement of dual lead permanent pacemaker | 18 | $270 | $938 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 18 | $131 | $841 |
| Hospital follow-up visit, high complexity | 17 | $94 | $262 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 16 | $52 | $224 |
| Insertion of tube in right and left heart chambers, coronary artery, and bypass graft for diagnosis with review by radiologist | 15 | $348 | $1,110 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 15 | $42 | $254 |
| External shock to heart to regulate heart beat | 14 | $88 | $398 |
| Hospital discharge day management, 30 minutes or less | 12 | $64 | $183 |
| Lipid panel (cholesterol and triglycerides) | 11 | $13 | $34 |
| Blood glucose (sugar) level | 11 | $4 | $10 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 11 | $80 | $348 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $109 | $641 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.4% high complexity
26.8% medium
59.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,432
Total received (2018-2024)
Avg $2,205/year across 7 years
Top 17% in FL for cardiovascular disease
43
Companies
333
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,432 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,933
2023$3,549
2022$1,517
2021$994
2020$674
2019$3,561
2018$3,204
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$5,008
Abbott Laboratories
$3,012
Boston Scientific Corporation
$677
Janssen Pharmaceuticals, Inc
$615
ShockWave Medical, Inc
$579
Novartis Pharmaceuticals Corporation
$577
Amgen Inc.
$458
BOSTON SCIENTIFIC CORPORATION
$456
Shockwave Medical, Inc
$437
ABIOMED
$429
Boehringer Ingelheim Pharmaceuticals, Inc.
$354
AstraZeneca Pharmaceuticals LP
$308
Medtronic, Inc.
$235
PFIZER INC.
$234
Merck Sharp & Dohme LLC
$234
E.R. Squibb & Sons, L.L.C.
$218
Biosense Webster, Inc.
$171
Esperion Therapeutics, Inc.
$145
Daiichi Sankyo Inc.
$127
Amarin Pharma Inc.
$125
Novo Nordisk Inc
$111
BIOTRONIK INC.
$103
Teleflex LLC
$81
Chiesi USA, Inc.
$76
Impulse Dynamics (USA) Inc.
$73
Lexicon Pharmaceuticals, Inc.
$68
Cardiovascular Systems Inc.
$66
Kestra Medical Technology Services, Inc.
$54
CARDIVA MEDICAL, INC.
$52
Bayer Healthcare Pharmaceuticals Inc.
$48
Cardinal Health 200, LLC
$47
Opsens Inc.
$39
Coala Life Inc
$30
Kiniksa Pharmaceuticals International, plc
$30
GE HealthCare
$26
CHIESI USA, INC.
$23
Lundbeck LLC
$19
Merck Sharp & Dohme Corporation
$16
Medtronic USA, Inc.
$15
SCPHARMACEUTICALS INC.
$15
Kowa Pharmaceuticals America, Inc.
$14
Penumbra, Inc.
$12
CathWorks, Inc.
$12
Top 3 companies account for 56.4% of total payments
Associated products mentioned in payments ›
AMPLATZER AMULET · AVEIR · Advisa · Arcalyst · Assure WCD · Azure · BIOMONITOR · BRILINTA · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CHANTIX · COMET · CONCERTOTM · CardioMEMS HF System · CareLink · ClosureFast · Coala Heart Monitor · Confirm Rx · Connectivity and Remote care · Corlanor · Coronary Orbital Atherectomy System · Diamondback Coronary · ELIQUIS · ENTRESTO · FARXIGA · FFR LINK · FFRangio System · FUROSCIX · GALLANT · GENERAL STENTS · GENERAL STENTS · Hi-Torque Balance guide wires · INJECTAFER · Impella · Indigo System · Inpefa · JARDIANCE · JOT DX · KENGREAL · KENGREAL 50MG/10ML L · KYPHON Balloon Kyphoplasty · Kerendia · LEQVIO · LINQ II · LUX-Dx Insertable Cardiac Monitor · Livalo · MICRA · Merlin Connectivity and Remote · Micra · NA · NEXLETOL · NEXLIZET · NORTHERA · NUVISION ICE CATHETER · OPTIMIZER · OptoWire · Pacemakers · Peripheral Orbital Atherectomy System · Quadra Assura CRT Defibrillator · RESOLUTE ONYX · REVEAL LINQ · Repatha · Resolute · Reveal LINQ · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TRAPLINER · TYRX · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · VenaSeal · Visia AF · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · Xience Sierra CSS · Xience Sierra Coronary Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $133 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
37
Per 100K population
6.0
County median income
$75,817
Nearest hospital
HOLMES REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Croft is a clinical cardiology specialist, with above-average Medicare volume (top 6% in FL), and high industry engagement (low-engagement, top 17%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Croft experienced with injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)?
Based on Medicare claims data, Dr. Croft performed 2,448 injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Croft receive payments from pharmaceutical companies?
Yes. Dr. Croft received a total of $15,432 from 43 companies across 333 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Croft's costs compare to other cardiovascular diseases in Melbourne?
Dr. Croft's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Croft) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Melbourne
Browse cardiovascular diseases in Melbourne ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology